All GemStar Family of Infusers: GemStar Infusion System - Single Therapy, GemStar 7 Therapy Infusion SystemGemStar Infusion System - Single Therapy 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Hospira Pty Limited 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00246-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2013-04-12
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
  • 원인
    During infusions at flow rates of less than 2.0ml/hr , the motor assembly may rotate backwards (roll back), capturing additional medication that will be delivered resulting in over-infusion. additionally, users may receive x09/001 backward motor movement alarms during the device’s power on self test (post) or during an infusion. this alarm will invoke visual and audible warnings to the user and the infusion will not begin or an active therapy will stop, resulting in a delay or interruption in therapy.
  • 조치
    Hospira is advising customers to refrain from using GemStar Infusion pumps on all Neonatal patient populations and infants up to 2 years of age, and any patients where therapy is delivered at flow rates less than 2.0mL/hour. If the GemStar device displays an X09/001 error, customers are advised to immediately remove it from clinical service and return it to Hospira for repair. Hospira is in consultation with the TGA for any further action. Healthcare professionals are advised to weigh the risk/benefit to patients associated with the use of the device when administering critical therapies. Customers should consider the use of an alternative pump, particularly in patients in which delay/interruption in therapy or under/over infusion could result in significant injury or death.

Device

  • 모델명 / 제조번호(시리얼번호)
    All GemStar Family of Infusers: GemStar Infusion System - Single Therapy, GemStar 7 Therapy Infusion SystemGemStar Infusion System - Single TherapyCatalogue number: 611308801Number on pump: 13088/13150GemStar 7 Therapy Infusion SystemCatalogue number: 611308701Number on pump: 13087/13000
  • 의료기기 분류등급
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DHTGA